US Patent Issued to Apellis Pharmaceuticals on May 6 for "Dosing regimens and related compositions and methods" (American, Swiss Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,290,566, issued on May 6, was assigned to Apellis Pharmaceuticals Inc. (Waltham, Mass.).

"Dosing regimens and related compositions and methods" was invented by Federico Grossi (Needham, Mass.), Pascal Deschatelets (West Newton, Mass.), Cedric Francois (Prospect, Ky.), Patrick Johnson (Zurich) and Carolina Vega (Berkeley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In some aspects, the present invention provides cell-reactive compstatin analogs and compositions comprising cell-reactive compstatin analogs. In some aspects, the invention further provides methods of using cell-reactive compstatin analogs, e.g., treat a complement-mediated disorder...